SC
AGL icon

Scotia Capital’s Agilon Health AGL Stock Holding History

Scotia Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,303
Closed -$1.66M – 829
2023
Q4 		$1.66M Buy
5,303
+70
+1% +$25.3K 0.01% 382
2023
Q3 		$2.32M Buy
+5,233
New +$2.36M 0.02% 320

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Scotia Capital's AGL Position: Q1 2024 in Review

Scotia Capital sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 5,303 shares — an estimated $1.66M sold.

Scotia Capital first reported a position in AGL in Q3 2023 and held it in 2 quarters. The position peaked at $2.32M in Q3 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Scotia Capital reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Scotia Capital sold 5,303 Agilon Health shares in Q1 2024, an estimated $1.66M.
  • Scotia Capital first reported a position in Agilon Health in Q3 2023 and held it in 2 quarters.
  • Scotia Capital's Agilon Health position peaked at $2.32M in Q3 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Scotia Capital's 13F filing for Q1 2024, filed 14 May 2024.